Patent ID: 11969460
Assignee: U.S. DEPARTMENT OF VETERNAS AFFAIRS
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 0:
1. A method of treating a subject in need thereof medically diagnosed with age-related cognitive decline and a decreased level of adropin compared to a previous level of adropin in the subject, the method comprising administering to the subject an effective amount of the adropin amino acid sequence of SEQ ID NO: 1 or the adropin34-76 peptide fragment amino acid sequence of SEQ ID NO: 2, wherein the effective amount is sufficient to delay or not allow further progression of age-related cognitive decline as determined by a medically diagnosing professional on a subject by subject basis as to the subject in need thereof; by measuring the before and after treatment results of any standard cognitive functioning test that specifically tests for age-related cognitive decline.